The first glucagon-like peptide-1 (GLP-1)-based therapeutic was approved by Health Canada in 2011 for the treatment of hyperglycemia in patients with Type 2 diabetes. Little was it suspected at...
Imagine not being able to eat a meal with family or friends. That is the case for people who have a condition known as short bowel syndrome (SBS). When large segments of the intestines are missing,...
RSS